Cytokinetics (CYTK) Insider Trading & Ownership $50.26 -0.86 (-1.68%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$50.26 0.00 (0.00%) As of 02/21/2025 05:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cytokinetics (NASDAQ:CYTK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$20.42 M Get CYTK Insider Trade Alerts Want to know when executives and insiders are buying or selling Cytokinetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CYTK Insider Buying and Selling by Quarter Cytokinetics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/18/2025Fady Ibraham MalikEVPSell2,000$45.98$91,960.00 2/4/2025Fady Ibraham MalikEVPSell2,000$48.06$96,120.00 1/21/2025Fady Ibraham MalikEVPSell2,000$45.92$91,840.00 1/7/2025Fady Ibraham MalikEVPSell2,000$49.32$98,640.00 12/16/2024Wendall WierengaDirectorSell742$48.61$36,068.62 12/11/2024John T HendersonDirectorSell1,780$50.42$89,747.60 12/10/2024Fady Ibraham MalikEVPSell7,300$50.64$369,672.00 12/2/2024Robert I BlumCEOSell5,000$50.76$253,800.00 11/26/2024Fady Ibraham MalikEVPSell7,300$50.16$366,168.00 11/18/2024Robert I BlumCEOSell5,000$50.55$252,750.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/12/2024Fady Ibraham MalikEVPSell6,342$58.48$370,880.16 11/1/2024Robert I BlumCEOSell5,000$51.63$258,150.00 10/30/2024Fady Ibraham MalikEVPSell7,300$51.91$378,943.00 10/28/2024Wendall WierengaDirectorSell4,452$52.25$232,617.00 10/15/2024Fady Ibraham MalikEVPSell7,300$54.19$395,587.00 10/9/2024Robert I BlumCEOSell5,000$55.61$278,050.00 10/1/2024Fady Ibraham MalikEVPSell7,300$52.10$380,330.00 9/30/2024Robert I BlumCEOSell5,000$52.14$260,700.00 9/3/2024Fady Ibraham MalikEVPSell7,384$57.01$420,961.84 9/3/2024Robert I BlumCEOSell5,000$57.03$285,150.00 8/12/2024B Lynne ParshallDirectorSell5,000$55.20$276,000.00 8/12/2024Robert I BlumCEOSell11,500$55.17$634,455.00 8/6/2024Fady Ibraham MalikEVPSell7,300$53.71$392,083.00 7/30/2024Robert I BlumCEOSell11,500$59.49$684,135.00 7/29/2024B Lynne ParshallDirectorSell5,000$59.84$299,200.00 7/23/2024Fady Ibraham MalikEVPSell7,300$57.02$416,246.00 7/15/2024B Lynne ParshallDirectorSell5,000$55.82$279,100.00 7/10/2024Robert I BlumCEOSell11,500$54.29$624,335.00 7/9/2024Fady Ibraham MalikEVPSell7,300$55.90$408,070.00 7/5/2024Robert Arthur HarringtonDirectorSell253$54.61$13,816.33 7/1/2024B Lynne ParshallDirectorSell5,000$54.22$271,100.00 7/1/2024Robert I BlumCEOSell11,500$54.05$621,575.00 6/25/2024Fady Ibraham MalikEVPSell7,300$53.72$392,156.00 6/17/2024B Lynne ParshallDirectorSell5,000$52.55$262,750.00 6/17/2024Robert I BlumCEOSell22,500$52.60$1,183,500.00 6/11/2024Fady Ibraham MalikEVPSell7,788$53.04$413,075.52 6/10/2024Muna BhanjiDirectorSell2,000$52.07$104,140.00 6/4/2024Robert I BlumCEOSell22,500$48.85$1,099,125.00 6/3/2024Robert Arthur HarringtonDirectorSell1,580$48.64$76,851.20 6/3/2024Robert WongCAOSell13,011$48.88$635,977.68 Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.You MUST act before March 17th.5/7/2024Fady Ibraham MalikEVPSell15,547$65.11$1,012,265.17 4/25/2024John T HendersonDirectorSell10,562$64.54$681,671.48 4/9/2024Fady Ibraham MalikEVPSell32,605$74.31$2,422,877.55 3/5/2024Fady Ibraham MalikEVPSell32,604$67.56$2,202,726.24 (Data available from 1/1/2013 forward) CYTK Insider Trading Activity - Frequently Asked Questions Who is on Cytokinetics's Insider Roster? The list of insiders at Cytokinetics includes B Lynne Parshall, Ching Jaw, Fady Ibraham Malik, John T Henderson, Mark A Schlossberg, Muna Bhanji, Robert Arthur Harrington, Robert I Blum, Robert Wong, Santo J Costa, and Wendall Wierenga. Learn more on insiders at CYTK. What percentage of Cytokinetics stock is owned by insiders? 3.40% of Cytokinetics stock is owned by insiders. Learn more on CYTK's insider holdings. Which Cytokinetics insiders have been selling company stock? The following insiders have sold CYTK shares in the last 24 months: B Lynne Parshall ($1,388,150.00), Fady Ibraham Malik ($15,762,651.92), John T Henderson ($1,736,868.90), Muna Bhanji ($172,380.00), Robert Arthur Harrington ($90,667.53), Robert I Blum ($17,385,225.00), Robert Wong ($635,977.68), and Wendall Wierenga ($1,197,446.02). How much insider selling is happening at Cytokinetics? Insiders have sold a total of 728,606 Cytokinetics shares in the last 24 months for a total of $38,369,367.05 sold. Cytokinetics Key ExecutivesMr. Robert I. Blum (Age 60)President and Chief Executive Officer Compensation: $1.33M6 recent tradesMr. Robert C. Wong (Age 56)VP & Chief Accounting Officer Compensation: $495.72kDr. Fady Ibraham Malik FACC (Age 60)M.D., Ph.D., Executive Vice President of Research & Development Compensation: $839.66kMr. Andrew M. Callos (Age 55)Executive VP & Chief Commercial Officer Compensation: $752.84kDr. James A. Spudich Ph.D. (Age 82)Co-Founder & Member of Scientific Advisory Board Compensation: $21.94kMr. Jeff LotzVice President of Sales & OperationsMr. Matt YangVice President of Corporate Finance and Financial Planning & AnalysisMr. Steven M. Cook (Age 65)Senior Vice President of Global Supply Chain Operations & Technical Operations Ms. Kari K. Loeser J.D.VP & Chief Compliance OfficerMr. John O. Faurescu Esq.VP, Associate General Counsel & Corporate Secretary More Insider Trading Tools from MarketBeat Related Companies TEVA Insider Transactions SMMT Insider Transactions GMAB Insider Transactions ITCI Insider Transactions VTRS Insider Transactions MRNA Insider Transactions PCVX Insider Transactions SRPT Insider Transactions ROIV Insider Transactions RVMD Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:CYTK) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYTK Stock Alerts